The Law of Compounding Medications And Drugs: FDA Guidance: Adverse Event Reporting for Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act Guidance for Industry (PDF - 138KB)

Thursday, October 8, 2015

FDA Guidance: Adverse Event Reporting for Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act Guidance for Industry (PDF - 138KB)

October 7, 2015

Adverse Event Reporting for Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act
Guidance for Industry (PDF - 138KB)

No comments:

Subscribe to: Post Comments (Atom)